A phase Ib, multicenter, open-label study of NXP800, a novel GCN2 kinase activator, among patients with platinum-resistant, ARID1A-mutated ovarian cancer (ENGOT-GYN5/NCRI/NXP800-101; GOG-3087)
Susana Banerjee,Ramez N. Eskander,Patricia Roxburgh,David M. O’Malley,Ana Oaknin,Joyce Barlin,Els Van Nieuwenhuysen,Charles Anderson,Jean‐François Baurain,Lindsay W. Brubaker,Joo Ern Ang,Noelle Cloven,Andrés Redondo,Bradley Monk,Isabelle Ray‐Coquard,Kathleen N. Moore,Dominique Berton-Rigaud,Megan Sardone,Diane Marsolini,Shannon N. Westin
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
cdercder
CFD
Scorpia112
小牛马阿欢
YWY
尊嘟假嘟
ffrrss
OK
学术文献互助
殷勤的紫槐
GingerF
科研狗
我是小汪
畔畔
寮信
8R60d8
碎觉觉
东方元语
可可
皖公网安备34019202002308
